Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharyn D Baker

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Clinical and Translational Science|April 8, 2019
Interaction Between Sex and Organic Anion-Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib-N-Oxide and Regorafenib-Glucuronide in MiceQiang Fu, Mingqing Chen, Jason T Anderson, et al.
Journal of the National Cancer Institute|December 7, 2006
CYP3A phenotyping approach to predict systemic exposure to EGFR tyrosine kinase inhibitorsJing Li, Mats O Karlsson, Julie Brahmer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 2, 2020
Role of Oatp2b1 in Drug Absorption and Drug-Drug InteractionsMingqing Chen, Shuiying Hu, Yang Li, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 31, 2005
Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometryMing Zhao, Carol Hartke, Antonio Jimeno, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 2, 2022
Determination of the endogenous OATP1B biomarkers glycochenodeoxycholate-3-sulfate and chenodeoxycholate-24-glucuronide in human and mouse plasma by a validated UHPLC-MS/MS methodYan Jin, Yang Li, Eric D Eisenmann, et al.
Molecules (Basel, Switzerland)|October 27, 2022
Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1BDominique A Garrison, Yan Jin, Zahra Talebi, et al.
Pharmacotherapy|January 27, 2004
Temozolomide in patients with advanced cancer: phase I and pharmacokinetic studyMichelle A Rudek, Ross C Donehower, Paul Statkevich, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 28, 2010
Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometryLie Li, Ming Zhao, Fariba Navid, et al.
Pediatric Blood & Cancer|June 22, 2013
Alternative formulations of sorafenib for use in childrenFariba Navid, Robbin Christensen, Hiroto Inaba, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 24, 2004
Quantification of 5-azacytidine in plasma by electrospray tandem mass spectrometry coupled with high-performance liquid chromatographyMing Zhao, Michelle A Rudek, Ping He, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Clinical and Translational Science|April 8, 2019
Interaction Between Sex and Organic Anion-Transporting Polypeptide 1b2 on the Pharmacokinetics of Regorafenib and Its Metabolites Regorafenib-N-Oxide and Regorafenib-Glucuronide in MiceQiang Fu, Mingqing Chen, Jason T Anderson, et al.
Journal of the National Cancer Institute|December 7, 2006
CYP3A phenotyping approach to predict systemic exposure to EGFR tyrosine kinase inhibitorsJing Li, Mats O Karlsson, Julie Brahmer, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 2, 2020
Role of Oatp2b1 in Drug Absorption and Drug-Drug InteractionsMingqing Chen, Shuiying Hu, Yang Li, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 31, 2005
Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometryMing Zhao, Carol Hartke, Antonio Jimeno, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 2, 2022
Determination of the endogenous OATP1B biomarkers glycochenodeoxycholate-3-sulfate and chenodeoxycholate-24-glucuronide in human and mouse plasma by a validated UHPLC-MS/MS methodYan Jin, Yang Li, Eric D Eisenmann, et al.
Molecules (Basel, Switzerland)|October 27, 2022
Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1BDominique A Garrison, Yan Jin, Zahra Talebi, et al.
Pharmacotherapy|January 27, 2004
Temozolomide in patients with advanced cancer: phase I and pharmacokinetic studyMichelle A Rudek, Ross C Donehower, Paul Statkevich, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 28, 2010
Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometryLie Li, Ming Zhao, Fariba Navid, et al.
Pediatric Blood & Cancer|June 22, 2013
Alternative formulations of sorafenib for use in childrenFariba Navid, Robbin Christensen, Hiroto Inaba, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 24, 2004
Quantification of 5-azacytidine in plasma by electrospray tandem mass spectrometry coupled with high-performance liquid chromatographyMing Zhao, Michelle A Rudek, Ping He, et al.
Pageof 17